Empowering Access to Venture
Epic Venture Partners brings together a network of seasoned investors and industry experts to identify, evaluate, and support high-potential opportunities. Our unique approach ensures that each investment is guided by the insight of those who understand the technology, markets, and challenges involved. By connecting expertise with capital, we create a collaborative and informed process that drives successful outcomes for both investors and portfolio companies.
Like-minded investors and experts who share opportunities, support ventures, and grow together.
Backing Leaders and Innovators
Rain AI is revolutionizing the future of artificial intelligence with the most energy-efficient hardware ever developed. By enabling advanced AI models to run directly on devices, their technology accelerates the speed, effectiveness, and accessibility of AI across industries—from healthcare and defense to consumer electronics and beyond.
Fastwave Medical is revolutionizing the treatment of calcific artery disease, a $10B+ market, with advanced intravascular lithotripsy (IVL) systems. Their easy-to-use, rupture-resistant balloon catheter platform delivers predictable sonic output, greater energy pulse availability, and valuable real-time procedural feedback.
Solenic is transforming implant infection care with its patented Alternating Magnetic Field (AMF) technology, a non-invasive solution that eradicates biofilm on metallic implants without the need for costly and risky revision surgeries. By targeting a significant clinical need, Solenic’s groundbreaking approach offers safer, more effective treatment options and promises to revolutionize the standard of care for implant infections in a growing market.
Sprout Opportunity Fund II is a strategic addition to our portfolio, offering access to late-stage private technology companies backed by top-tier venture capital firms. By targeting the $1.8B+ annual market opportunity where employees abandon vested stock options, Sprout unlocks undervalued equity, delivering significant growth potential through a carefully curated portfolio of 10-15 innovative, high-performing companies.
Leading investment decisions with decades of combined experience.
General Partner
Arthur Lee, MD, is a nationally and internationally recognized expert in the field of peripheral vascular disease and critical limb ischemia. With board certifications in Interventional Cardiology, Nuclear Cardiology, Echocardiology, and Internal Medicine, Dr. Lee brings unparalleled expertise in his role as Dirctor of Perpheral Vascular Services at The Cardiac & Vascular Institute (TCAVI).
Dr. Lee has made significant contributions to the field through his extensive publications and articles and has delivered lectures at prestigious national and international conferences. His clinical interests encompass Interventional Cardiology, Peripheral Vascular Disease (including both arterial and venous systems), Critical Limb Ischemia, and Preventive Cardiology.
General Partner
Bryan Edelstein is a successful serial entrepreneur with a proven track record of building and scaling businesses across multiple industries; including hospitality, media production, healthcare, and tech. In one of his most recent successes he navigated the complex legal and regulatory framework required to obtain one of the first medical cannabis licenses in the state of Florida. From that initial success, he expanded his footprint in the industry by securing additional licenses and strategically deploying capital across the sector, including investments in real estate, structured senior debt, and other high-growth opportunities.
Bryan's proven track record in business became the springboard for a broader pursuit: strategic investments across a diverse set of asset classes. From private debt to venture funding, his investment strategy encompasses both established sectors and emerging opportunities, identifying unique opportunities with a compelling risk-reward profile. Across his ventures and external opportunities, Bryan has demonstrated exceptional fundraising acumen, successfully raising over $100 million in a combination of debt and equity to fuel growth and innovation. Known for his unique perspective spanning both entrepreneurship and investment, Bryan has built a reputation for identifying untapped potential and nurturing lasting portfolio value.
Bryan sits on several boards and his experience extends to advising startups on capital structure, deal negotiation, investor relations, and navigating the fundraising process.
General Partner
José Luna embarked on his entrepreneurial journey when he joined his first early-stage startup more than 20 years ago, developing innovative decisions-support tools to empower physicians at the point of care. Since then, José has built a distinguished career as a technology entrepreneur, consistently operating and scaling successful technology companies. With a unique blend of technical expertise and business acumen, he has gained a deep understanding of what it takes to build successful organizations. In his most recent success, his R&D team was acquired by the market leader in the federal benefits space and he served as CTO over an international team of 80+ software and machine learning engineers. The generative AI solutions that he personally contributed had a direct impact to the bottom line measuring in the tens of millions.
José’s entrepreneurial roots provided the perfect foundation for his evolution into a strategic investor. With experience building and scaling technology companies, he brings a founder’s perspective to identifying and nurturing high-growth opportunities. His investment strategy bridges a wide range of asset classes, guided by a focus on long-term value creation. José continues to consult for organizations large and small in machine learning and generative AI.
A comprehensive panel interview exploring the latest advances in treating calcific PAD through intravascular lithotripsy technology.
Epic Venture Partners leads significant investment in Rain AI, supporting the company's rapid growth and increasing market demand for its innovative solutions.
FastWave Medical strengthens its intellectual property portfolio with a new patent for its innovative intravascular lithotripsy technology.
Analysis of FastWave Medical's position in the growing cardiovascular market, highlighting the company's innovative approach to intravascular lithotripsy.
Rain AI strengthens its leadership team with key hire from Apple, advancing its mission to revolutionize AI processor technology.
An in-depth look at revolutionary innovations in cardiovascular care, featuring breakthroughs in heart health technology.
Strategic partnership announcement between Rain AI and Andes Technology for RISC-V development.
Rain AI strengthens its team with the addition of a leading architect to advance its mission of making advanced AI accessible everywhere.
Positive clinical results from FastWave Medical's first human trial of their advanced peripheral IVL system.